Cargando…
COVID-19 and obesity: fighting two pandemics with intermittent fasting
Obesity is strongly and independently associated with an increased risk of severe illness and death from coronavirus disease 2019 (COVID-19). The pathophysiological changes that result from elevated body weight lead to metabolic dysfunction, chronic inflammation, impaired immunological responses, an...
Autores principales: | Ealey, Kafi N., Phillips, Joy, Sung, Hoon-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226104/ https://www.ncbi.nlm.nih.gov/pubmed/34275726 http://dx.doi.org/10.1016/j.tem.2021.06.004 |
Ejemplares similares
-
Fighting the obesity pandemic during the COVID-19 pandemic
por: Grubbs, Jordan E., et al.
Publicado: (2022) -
Characterization of adipose depot-specific stromal cell populations by single-cell mass cytometry
por: Lee, Ju Hee, et al.
Publicado: (2022) -
Brain–Gut–Microbiome Interactions and Intermittent Fasting in Obesity
por: Frank, Juliette, et al.
Publicado: (2021) -
Intermittent Fasting: Potential Bridge of Obesity and Diabetes to Health?
por: Zang, Bo-Ying, et al.
Publicado: (2022) -
Intermittent Fasting and Metabolic Health
por: Vasim, Izzah, et al.
Publicado: (2022)